Chemical shift magnetic resonance imaging could predict subclinical cortisol production from an incidentally discovered adrenal mass.


Yener S., SEÇİL M., Demir O., Saydam B. O., YÖRÜKOĞLU K.

Clinical endocrinology, vol.88, no.6, pp.779-786, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 88 Issue: 6
  • Publication Date: 2018
  • Doi Number: 10.1111/cen.13587
  • Journal Name: Clinical endocrinology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.779-786
  • Keywords: Adrenal incidentaloma, Hypercortisolism, magnetic resonance imaging, CLINICAL-PRACTICE GUIDELINE, CUSHINGS-SYNDROME, ADRENOCORTICAL ADENOMAS, HYPERCORTISOLISM, MANAGEMENT, SOCIETY, MUTATION, PRKACA, TUMORS
  • Dokuz Eylül University Affiliated: Yes

Abstract

ContextTo investigate whether any association between chemical shift magnetic resonance (MRI) findings, cortisol secretion and pathological findings exists that could predict subclinical hypercortisolism (SCH) in patients with adrenal incidentalomas (AI).